Seeking Alpha

BullRyder's  Instablog

BullRyder
Send Message
later
View BullRyder's Instablogs on:
  • Penny Stock On Steroids: Billion Dollar Penny Stock! Is $VMRI Really Worth A Billion Dollar? Find Out

    Daily Stock Deals

    Daily Stock Deals @TOP10STOCKS

    Billion Dollar Penny Stock! is $VMRI Really Worth a Billion Dollar? find out http://oxbridgeresearch.com/docs/VMRI,%20Valmie%20Resources.pdf … #pennystocks #hot

    Mar 23 2:22 PM | Link | Comment!
  • Premier Biomedical | BIEI | Profile | Summary

    Premier Biomedical | BIEI | Profile | Summary

    Premier Biomedical (OTCQB:BIEI) is a research-based company that has acquired exclusive licenses for patent-pending medications and medical procedures to develop cures for a significant number of the most debilitating and often fatal illnesses: ALS, Traumatic Brain Injury, Multiple Sclerosis, Clinical Depression, Alzheimer's Disease, Blood Sepsis, and Cancer. The company is in the process of developing targeted medicines and procedures and will prove out their superior efficacy in addressing these diseases and others through laboratory, hospital, and actual patient applications. At the anticipated successful conclusion of the clinical trials, contact will be established with the leading worldwide pharmaceutical firms to establish the right to market and distribute Premier Biomedical's technology products and procedures.

    INVESTMENT HIGHLIGHTS

    · The Company's proprietary Sequential Dialysis Technique and patented candidate drug Feldetrex are expected to provide superior efficacy versus existing medications in treating a large number of the most fatal diseases

    o Alzheimer's Disease, Multiple Sclerosis, ALS, Fibromyalgia, Traumatic Brain Injury, Blood Sepsis, and Cancer

    · The Company has established two outstanding research partnerships with the University of Texas, El Paso (UTEP) and the Department of Defense

    o Leverage the substantial infrastructure and resourced capacity of these organizations to perform experimentation and to engage in product development in an inexpensive and efficient manner

    o Positive results in animal testing for the Sequential Dialysis Technique treatment of cancer

    o Initiation of two clinical trials including a trial for Feldetrex and a trial of the Sequential Dialysis Technique

    learn more download a free 28 page Research Report now! Click here

    EXECUTIVE SUMMARY

    · Premier Biomedical is a research-based company that intends to discover and develop medical treatments targeting the treatment of: Alzheimer's Disease, Multiple Sclerosis, ALS, Fibromyalgia, Traumatic Brain Injury, Blood Sepsis, and Cancer

    · The Company's proprietary Sequential Dialysis Technique is a methodology that physically removes the pathophysiologic basis of the disease, eliminating it without dangerous side effects

    o Superior to current treatments which eliminate the presence of most illnesses but often with catastrophic or even fatal side effects

    o Targets cancer, Alzheimer's disease, Multiple Sclerosis, ALS, blood sepsis, and Traumatic Brain Injury - collectively over $700 billion market opportunity

    · Developed a proprietary drug candidate Feldetrex as a potential treatment for Multiple Sclerosis, Fibromyalgia, and Traumatic Brain Injury

    o Expected to deliver significant relief to patients, while presenting fewer side effects than other alternate medications

    o The Company was recently granted two US patents for this drug candidate

    o The annual market size of all proposed market segments for Feldetrex is $16 billion

    · The Company has established two outstanding research partnerships with the University of Texas, El Paso (UTEP) and the Department of Defense

    o Leverage the substantial infrastructure and resourced capacity of these organizations to perform experimentation and to engage in product development in an inexpensive and efficient manner

    o Positive results in animal testing for the Sequential Dialysis Technique treatment of cancer

    o Initiation of two clinical trials including a trial for Feldetrex and a trial of the Sequential Dialysis Technique

    for more information download a comprehensive Research Report now

    Sources: The Company, OxBridge Research, OTCKING, DailyStockDeals, OTCstockIQ

    Don't miss the NEXT premium Alert! Sign-up, Get Alerts,MakeMoney

    Disclaimer/Disclosure: we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

    If you would like your company featured or want to learn more, please don't hesitate to contact the Editor. editor [@] OTCking.com

    Mar 23 12:19 AM | Link | Comment!
  • SDIG, Station Digital, New Nationwide Launch, FREE Music & Earn Rewards

    StationDigital Corporation

    Multimedia Digital Broadcasting

    StationDigital, SDIG, is a multimedia digital broadcast company that offers free music streaming of over 30 million songs. StationDigital features both genre-based and artist-based music discovery stations to suit an endless variety of musical tastes, and a personal recommendation service to its more than 2.4 million unique listeners - all available both online and through its iOS and Andriod mobile apps. StationDigital's users can customize their listening experience by selecting playlists and stations based on themes, interests and location, as well as favorite artists, songs, genre, and by providing feedback on the music they hear.

    StationDigital is the first truly next generation digital media broadcast platform.

    StationDigital's primary identity is as a sophisticated pure play music discovery Internet radio service, offering a competitive, state of the art product to capture market share in the Internet radio space. The Company has a unique, industry first value proposition - the StationDigital Listener Rewards Program, where all registered users earn listener rewards points:

    > Every time users listen to StationDigital, either on the web or through their mobile apps

    > Every time users share StationDigital with friends through social media

    Key Features:

    Social features and network effect - feedback on music, share music with friends and family, recommendations, post favorites on timeline, and earn reward points. Users can gain followers and build their own music social network of friends and fans.

    Unique personalization of music to user's taste - choose genre, artist, decade and ability to narrow search to a very specific target to get to songs faster. Features include ability to adjust music preferences, create a station playlist, and leverage songs from community of users.

    Music discovery - with over 30 million songs and hundreds of stations providing a wide variety of categories and genres, users are always able to discover something new. Add/remove stations with one touch, smooth intuitive song catalog, 30 million songs, choose decade, genre, artist.

    StationDigital will become the first agnostic, multimedia, global broadcast platform - available on any device, from anywhere, at anytime.

    Investment Highlights

    Opportunity to invest in an innovative, early stage next generation multimedia broadcast company with a unique and differentiated service and business model aimed at a rapidly growing and large market opportunity

    The Company's music streaming service has over 30 million songs for its 2.4 million users that offers customized listening, music discovery, a personal recommendation engine, a value-added social layer, and e-commerce platform

    Key competitive differentiation factors are its unique listener rewards program/online store and wide variety of entertainment content options beyond music

    Music streaming industry is still in its early stages and is experiencing rapid growth and market share capture from a large addressable $15 billion US radio market

    Our valuation analysis results in a target price of $0.81 per share which represents significant upside of over 2 times the current stock price

    see Investment Thesis click here

    VALUATION

    Starting with Pandora's market cap per user of $38.63 and then applying a 65% discount to account for Pandora's first mover advantage, dominant competitive position, and execution track record, we arrived at a market cap per user of $13.52. Based on management's aggressive marketing plan, it can be estimated that StationDigital will have approximately 5 million monthly active users by the end of 2016. Applying this $13.52 market cap per user to 5 million monthly active user results in a StationDigital target market capitalization of $67.6 million or price per share of $0.81.

    Our target price of $0.81 is over 2.0 times the current share price of $0.40 providing significant upside price potential while also being only 35% above the Company's recent high of $0.60 last October.

    learn more about this great opportunity,

    download the full research report now! click here

    visit the company website www.StationDigitial.com

    Start Enjoying the Music You Love!

    Sources: The Company, OxBridge Research, OTCKING, DailyStockDeals, OTCstockIQ

    Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney

    Disclaimer/Disclosure: we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

    If you would like your company featured or want to learn more, please don't hesitate to contact the Editor. editor [@] OxBridgeResearch.com

    Mar 22 9:46 PM | Link | Comment!
Full index of posts »
Latest Followers

StockTalks

  • Immnuocellular Therapeutics | IMUC | Profile | Summary $IMUC http://seekingalpha.com/p/1jr2r
    Jan 21, 2014
  • Social Network play TCLN looks good today! TCLN.OB is a small cap social media company that shares ad revenues with its members
    Jun 9, 2010
More »

Latest Comments


Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.